Repatha works by blocking a specific enzyme in your liver to help your body remove cholesterol more effectively. It doesn’t work by suppressing the immune system, but as a side effect, it can ...

The company’s Repatha (evolocumab) was added to optimised statin therapy in a phase 3 trial, and resulted in statistically significant regression of atherosclerosis in patients with coronary ...

Amgen's cholesterol-lowering antibody Repatha is being launched in Europe at well below the new drug's cost in the US, raising the chance that American payers will seek hefty discounts on the drug.